Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure

Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure

US Patent 4818749 · Granted Apr 4, 1989

Estimated economic value: $15,938,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as HIV protease inhibitors2020
Compounds inhibiting leucine-rich repeat kinase enzyme activity2016
Heterocyclic aspartyl protease inhibitors2014
Bicyclic heterocycle derivatives and use thereof as GPR119 modulators2014
Bicyclic heterocycle derivatives and methods of use thereof2014
Heterocyclic aspartyl protease inhibitors2014
Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity an2014
Heterocyclic aspartyl protease inhibitors2014
Heterocyclic aspartyl protease inhibitors2014
Substituted triazolopyridines and analogs thereof2014
Substituted [1,2,4]triazolo[4,3-alpha]quinoxalines as adenosine A2a receptor ant2013
Adenosine A2a receptor antagonists2013